Your Messages Inbox
Your Article Summary
See Latest ArticlesAPP Pharmaceuticals Receives Manufacturing Approval for Three Product Codes of Heparin at Puerto Rico Facility
American Pharmaceutical Partners, 03/31/09
APP Pharmaceuticals, Inc., a leading provider of hospital-based injectable pharmaceutical products, said that the U.S Food and Drug Administration has approved APP's manufacturing facility in Barceloneta, Puerto Rico for the manufacture of three product codes of Heparin Sodium Injection, USP. "Bringing this third manufacturing site on-line is an important part of our commitment to ensuring that an uninterrupted and safe supply of heparin of the highest quality is available for U.S. patients," said Tom Silberg, chief executive officer of APP Pharmaceuticals.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Recombinant Human Erythropoietin, Epogin Injection
Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09
Synthon announces European approvals for Raloxifene
Synthon, 12/08/09
US FDA approves SEROQUEL for the pediatric treatment of schizophrenia and bipolar mania
AstraZeneca, 12/07/09
Article Search
Sponsor